Bai-Yan Li Selected Research

Conditioned Culture Media

6/2022	Generation of the Chondroprotective Proteomes by Activating PI3K and TNFα Signaling.
1/2022	Suppression of breast cancer-associated bone loss with osteoblast proteomes via Hsp90ab1/moesin-mediated inhibition of TGFβ/FN1/CD44 signaling.
1/2022	Counterintuitive production of tumor-suppressive secretomes from Oct4- and c-Myc-overexpressing tumor cells and MSCs.
11/2021	Conversion of Osteoclasts into Bone-Protective, Tumor-Suppressing Cells.
7/2021	Overexpression of Lrp5 enhanced the anti-breast cancer effects of osteocytes in bone.
3/2021	Inhibition of the Growth of Breast Cancer-Associated Brain Tumors by the Osteocyte-Derived Conditioned Medium.
1/2021	Generation of the tumor-suppressive secretome from tumor cells.
1/2021	Preventing tumor progression to the bone by induced tumor-suppressing MSCs.
1/2020	Skeletal loading regulates breast cancer-associated osteolysis in a loading intensity-dependent fashion.
1/2019	Vinculin Force Sensor Detects Tumor-Osteocyte Interactions.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Bai-Yan Li Research Topics

Disease

21	Neoplasms (Cancer) 07/2022 - 01/2017
13	Breast Neoplasms (Breast Cancer) 07/2022 - 01/2017
5	Neoplasm Metastasis (Metastasis) 07/2021 - 01/2017
4	Hypertension (High Blood Pressure) 01/2022 - 01/2016
3	Osteolysis 01/2022 - 01/2021
3	Fibrosis (Cirrhosis) 01/2019 - 01/2015
2	Carcinogenesis 01/2022 - 01/2022
2	Brain Neoplasms (Brain Tumor) 05/2021 - 03/2021
2	Bone Resorption 02/2018 - 01/2018
1	Chondrosarcoma 06/2022
1	Arthritis (Polyarthritis) 06/2022
1	Cardiac Arrhythmias (Arrythmia) 01/2021
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2021
1	Ventricular Tachycardia 01/2021
1	Essential Hypertension 01/2020
1	Infarction (Infarctions) 01/2019
1	Heart Diseases (Heart Disease) 01/2019
1	Reperfusion Injury 01/2019
1	Atrial Fibrillation 01/2019
1	AIDS-Related Complex (ARC) 01/2019
1	Myocardial Infarction 01/2019
1	Bone Fractures (Bone Fracture) 01/2018
1	Hyperinsulinism (Hyperinsulinemia) 01/2016
1	Heart Failure 09/2015

Drug/Important Bio-Agent (IBA)

11	Conditioned Culture MediaIBA 06/2022 - 01/2018
8	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2018
4	CateninsIBA 01/2022 - 01/2021
3	Volatile Organic CompoundsIBA 07/2022 - 12/2019
3	ProteomeIBA 06/2022 - 01/2022
3	Phosphopyruvate Hydratase (Enolase)IBA 01/2022 - 01/2021
3	FructoseIBA 04/2020 - 01/2016
2	pitavastatin (itavastatin)FDA Link 07/2022 - 12/2019
2	Biomarkers (Surrogate Marker)IBA 07/2022 - 01/2020
2	OsteopontinIBA 01/2022 - 01/2020
2	NG-Nitroarginine Methyl Ester (L-NAME)IBA 01/2022 - 04/2020
2	VinculinIBA 01/2022 - 01/2019
2	Dopamine (Intropin)FDA LinkGeneric 05/2021 - 01/2018
2	Fluphenazine (Prolixin)FDA LinkGeneric 05/2021 - 01/2018
2	Peptidylprolyl Isomerase (Prolyl Isomerase)IBA 01/2021 - 01/2019
2	AMP-Activated Protein KinasesIBA 01/2020 - 01/2019
2	fibroblast growth factor 21IBA 01/2020 - 01/2016
2	Transcription Factors (Transcription Factor)IBA 12/2019 - 01/2018
2	PD 407824IBA 09/2018 - 01/2018
2	NFATC Transcription FactorsIBA 09/2018 - 01/2018
2	DNA (Deoxyribonucleic Acid)IBA 02/2018 - 01/2017
2	Dopamine Receptors (Dopamine Receptor)IBA 01/2018 - 01/2017
1	4-sulfophenylmethallyl ether (SPME)IBA 07/2022
1	Therapeutic UsesIBA 01/2022
1	arginine methyl esterIBA 01/2022
1	moesinIBA 01/2022
1	ChemokinesIBA 07/2021
1	Antipsychotic Agents (Antipsychotics)IBA 05/2021
1	Tyrosine 3-Monooxygenase (Tyrosine Hydroxylase)IBA 05/2021
1	CytokinesIBA 05/2021
1	EnzymesIBA 05/2021
1	Histones (Histone)IBA 03/2021
1	Ubiquitin CIBA 01/2021
1	adhesion receptorIBA 01/2021
1	CarcinogensIBA 01/2021
1	Dantrolene (Dantrium)FDA LinkGeneric 01/2021
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 01/2021
1	Isoflurane FDA LinkGeneric 01/2021
1	RyanodineIBA 01/2021
1	CalreticulinIBA 01/2021
1	MelanocortinsIBA 04/2020
1	Nitroarginine (NG Nitro L Arginine)IBA 04/2020
1	LeptinIBA 04/2020
1	Myosin Type IIIBA 01/2020
1	Matrix Metalloproteinase 9 (Gelatinase B)IBA 12/2019
1	Mevalonic Acid (Mevalonate)IBA 12/2019
1	Bone Morphogenetic Protein 2IBA 12/2019
1	Pharmaceutical PreparationsIBA 12/2019
1	CholesterolIBA 12/2019
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 12/2019
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 12/2019
1	Fenofibrate (CiL)FDA LinkGeneric 02/2019
1	Serotonin ReceptorsIBA 01/2019
1	SodiumIBA 01/2019
1	LipopolysaccharidesIBA 01/2019
1	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2019
1	Tacrolimus Binding Protein 1A (FKBP12)IBA 01/2019
1	Tacrolimus Binding Proteins (FKBP)IBA 01/2019
1	Serotonin (5 Hydroxytryptamine)IBA 01/2019
1	Phosphotransferases (Kinase)IBA 09/2018
1	3- (carbamoylamino)- 5- (3- fluorophenyl)- N- (3- piperidyl)thiophene- 2- carboxamideIBA 09/2018
1	Checkpoint Kinase 1IBA 02/2018
1	ElementsIBA 01/2018
1	Sepharose (Agarose)IBA 01/2018
1	Trifluoperazine (Stelazine)FDA LinkGeneric 01/2018
1	CollagenIBA 01/2018
1	BiglycanIBA 01/2018
1	RNA (Ribonucleic Acid)IBA 01/2018
1	Collagen Type I (Type I Collagen)IBA 01/2018
1	S100 Calcium-Binding Protein A4IBA 01/2017
1	Messenger RNA (mRNA)IBA 01/2017
1	A 77636IBA 01/2017

Therapy/Procedure

3	Drug Therapy (Chemotherapy) 01/2022 - 09/2018
3	Therapeutics 07/2021 - 03/2021
1	Analgesia 01/2019
1	Parenteral Infusions 01/2016